• / Free eNewsletters & Magazine
  • / My Account
Home>Cure Duchenne Ventures LLC Provides $1 Million to MyoTherix to Advance Promising Research to Treat Duchenne Muscular Dystrophy

Cure Duchenne Ventures LLC Provides $1 Million to MyoTherix to Advance Promising Research to Treat Duchenne Muscular Dystrophy

3party Content

Tue, 1 Sep 2015

Cure Duchenne Ventures LLC Provides $1 Million to MyoTherix to Advance Promising Research to Treat Duchenne Muscular Dystrophy
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.